← Back to Cibo Flash
Earnings

Labixiaoxin (01262) announced interim results

  • RevenueRMB6.3bn
  • Net profitRMB-17.7M
  • Profit attributable to ownersRMB-17.7M
  • Revenue YoY+21.8%
  • Net profit YoY-800.1%
  • Depreciation & amortisationHK$30.7M
  • Capital expenditureHK$-86.4M
  • Interest-bearing debtHK$5.2bn

Source Labixiaoxin

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect